By Scott Maucione
“The Maryland Prescription Drug Affordability Board (PDAB) voted Monday to put payment caps on Ozempic for state and local governments, which will save those entities about $5.8 million annually. …”
“‘The Maryland PDAB decision to establish an upper payment limit is unlikely to meaningfully lower patient out-of-pocket costs and could ultimately make access to Ozempic more difficult for the people who rely on it,’ said coalition CEO Tiffany Westrich-Robertson.”